Pyxis Oncology GAAP EPS of -$1.28 misses by $0.93, revenue of $13.9M [Seeking Alpha]
Pyxis Oncology, Inc. (PYXS)
Company Research
Source: Seeking Alpha
As of December 31, 2025, Pyxis Oncology had cash and cash equivalents, including restricted cash, and short-term investments, of $68.3 million. The Company believes that its current cash, cash equivalents, and short-term investments will be sufficient to fund its operations into the fourth quarter of 2026. Fresh Stock Ideas, Every Day Explore diverse investing perspectives with daily analysis from experts across the market. Subscribe to Stock Ideas Sign Up More on Pyxis Oncology Seeking Alpha's Quant Rating on Pyxis Oncology Historical earnings data for Pyxis Oncology Financial information for Pyxis Oncology More Trending News
Show less
Read more
Impact Snapshot
Event Time:
PYXS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PYXS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PYXS alerts
High impacting Pyxis Oncology, Inc. news events
Weekly update
A roundup of the hottest topics
PYXS
News
- Pyxis Oncology (PYXS) had its price target lowered by Stifel Nicolaus from $9.00 to $8.00. They now have a "buy" rating on the stock.MarketBeat
- Pyxis Oncology (PYXS) had its "buy" rating reaffirmed by HC Wainwright. They now have a $7.00 price target on the stock.MarketBeat
- Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results [Yahoo! Finance]Yahoo! Finance
- Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial ResultsGlobeNewswire
- Pyxis Oncology (PYXS) was downgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=PYXS&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "hold" tMarketBeat
PYXS
Earnings
- 3/23/26 - Miss
PYXS
Sec Filings
- 3/25/26 - Form 4
- 3/25/26 - Form 4
- 3/25/26 - Form 4
- PYXS's page on the SEC website